Lead party: The Steele Foundation for Hope (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: AI Diagnostics (Pty) Ltd (private company) · Sector: Healthcare, Medical Equipment, Digital Health Platforms · Countries of operation: South Africa
Transaction type: Investment · Asset class: Venture Capital · Strategy: Venture Equity · Instrument: Ordinary Shares (Equity) · Round: Seed Extension / Pre-Series A · Deal amount: US$5.2m
Lead investor/buyer: The Steele Foundation for Hope · Investors/buyers: The Steele Foundation for Hope, iFSP Group, Global Innovation Fund
Legal advisers: not identified in the source record.
Source: announced 16 April 2026. Original announcement: techbuild.africa.


